Evidence map›Paper›PMID 40899150›Full record

ArticleGigaScience2025

Nanopore- and AI-empowered microbial viability inference.

Harika Ürel, Sabrina Benassou, Hanna Marti, Tim Reska, Ela Sauerborn, Yuri Pinheiro Alves De Souza, Albert Perlas, Enrique Rayo, Michael Biggel, Stefan Kesselheim and 9 more

Abstract read
In one paragraph

Article in GigaScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Harika ÜrelHelmholtz AI, Helmholtz Zentrum Muenchen, 85764 Neuherberg, Germany.ORCID 0009-0004-3732-4858
Sabrina BenassouJülich Supercomputing Center, Forschungszentrum Jülich, 52428 Jülich, Germany.ORCID 0009-0008-2049-9298
Hanna MartiInstitute of Veterinary Pathology, University of Zurich, 8057 Zurich, Switzerland.ORCID 0000-0002-8398-4708
Tim ReskaHelmholtz AI, Helmholtz Zentrum Muenchen, 85764 Neuherberg, Germany.ORCID 0009-0001-9700-5128
Ela SauerbornHelmholtz AI, Helmholtz Zentrum Muenchen, 85764 Neuherberg, Germany.ORCID 0000-0003-1347-0346
Yuri Pinheiro Alves De SouzaInstitute of Comparative Microbiome Analysis, Helmholtz Zentrum Muenchen, 85764 Neuherberg, Germany.ORCID 0000-0001-9854-6383
Albert PerlasHelmholtz AI, Helmholtz Zentrum Muenchen, 85764 Neuherberg, Germany.ORCID 0000-0002-4035-2436
Enrique RayoInstitute of Veterinary Pathology, University of Zurich, 8057 Zurich, Switzerland.ORCID 0000-0002-4497-4339
Michael BiggelInstitute for Food Safety and Hygiene, University of Zurich, 8057 Zurich, Switzerland.ORCID 0000-0002-1337-2132
Stefan KesselheimJülich Supercomputing Center, Forschungszentrum Jülich, 52428 Jülich, Germany.ORCID 0000-0003-0940-5752
Nicole BorelInstitute of Veterinary Pathology, University of Zurich, 8057 Zurich, Switzerland.ORCID 0000-0002-1556-9262
Edward J MartinInstitute of Ecology and Evolution, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3FL, UK.ORCID 0009-0000-4180-4900
Constanza B VenegasTechnical University of Munich, School of Life Sciences, 85354 Freising, Germany.ORCID 0000-0002-8359-8209
Michael SchloterTechnical University of Munich, School of Life Sciences, 85354 Freising, Germany.ORCID 0000-0003-1671-1125
Kathrin SchröderInstitute of Medical Microbiology, Immunology and Hygiene, Technical University of Munich, 81675 Munich, Germany.
Jana MittelstrassEidgenössische Forschungsanstalt für Wald, Schnee und Landschaft WSL, 8903 Birmensdorf, Switzerland.ORCID 0000-0001-5207-5520
Simone ProsperoEidgenössische Forschungsanstalt für Wald, Schnee und Landschaft WSL, 8903 Birmensdorf, Switzerland.ORCID 0000-0002-9129-8556
James M FergusonGarvan Institute of Medical Research, Sydney, NSW 2010, Australia.ORCID 0000-0002-6192-6937
Lara UrbanHelmholtz AI, Helmholtz Zentrum Muenchen, 85764 Neuherberg, Germany.ORCID 0000-0002-5445-9314

Funding

BBSRC BB/M010996/1Helmholtz Association Initiative and Networking FundHelmholtz Principal Investigator GrantMunich School for Data Science HIDSS-006STFC Food Network+ Scoping GrantUniversity of ZurichVontobel-Stiftung 1336/2004
6 · The paper itself

Abstract

backgroundThe ability to differentiate between viable and dead microorganisms in metagenomic data is crucial for various microbial inferences, ranging from assessing ecosystem functions of environmental microbiomes to inferring the virulence of potential pathogens from metagenomic analysis. Established viability-resolved genomic approaches are labor-intensive as well as biased and lacking in sensitivity.

resultsWe here introduce a new fully computational framework that leverages nanopore sequencing technology to assess microbial viability directly from freely available nanopore signal data. Our approach utilizes deep neural networks to learn features from such raw nanopore signal data that can distinguish DNA from viable and dead microorganisms in a controlled experimental setting of UV-induced Escherichia cell death. The application of explainable artificial intelligence (AI) tools then allows us to pinpoint the signal patterns in the nanopore raw data that allow the model to make viability predictions at high accuracy. Using the model predictions as well as explainable AI, we show that our framework can be leveraged in a real-world application to estimate the viability of obligate intracellular Chlamydia, where traditional culture-based methods suffer from inherently high false-negative rates. This application shows that our viability model captures predictive patterns in the nanopore signal that can be utilized to predict viability across taxonomic boundaries. We finally show the limits of our model's generalizability through antibiotic exposure of a simple mock microbial community, where a new model specific to the killing method had to be trained to obtain accurate viability predictions.

conclusionsWhile the potential of our computational framework's generalizability and applicability to metagenomic studies needs to be assessed in more detail, we here demonstrate for the first time the analysis of freely available nanopore signal data to infer the viability of microorganisms, with many potential applications in environmental, veterinary, and clinical settings.

Indexed as

Artificial IntelligenceMicrobial ViabilityNanoporesNanopore SequencingComputational BiologyEscherichia coliMetagenomics

Identifiers

PMID40899150
PMCPMC12405693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.